Publications in collaboration with researchers from Hospital Universitario Virgen del Rocío (10)

2023

  1. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression

    Frontiers in Immunology, Vol. 14

2022

  1. Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

    Scientific Reports, Vol. 12, Núm. 1

  2. Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance

    Frontiers in Immunology, Vol. 13

  3. The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection

    Translational Research, Vol. 239, pp. 103-123

2021

  1. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. The role of TNFR2 and DR3 in the in vivo expansion of tregs in t cell depleting transplantation regimens

    International Journal of Molecular Sciences, Vol. 21, Núm. 9

2019

  1. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT

    Cellular and Molecular Immunology, Vol. 16, Núm. 7, pp. 679-682

2015

  1. Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice

    Cell Transplantation, Vol. 24, Núm. 12, pp. 2423-2433

2013

  1. LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 541-551

2011

  1. B-and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity

    Transplantation, Vol. 92, Núm. 10, pp. 1085-1093